The Joint Corp. (NASDAQ:JYNT) Short Interest Update

The Joint Corp. (NASDAQ:JYNTGet Free Report) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 454,700 shares, a drop of 14.8% from the June 30th total of 533,600 shares. Based on an average trading volume of 64,200 shares, the short-interest ratio is currently 7.1 days.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of JYNT. Russell Investments Group Ltd. bought a new position in shares of Joint in the 4th quarter valued at $795,000. Skylands Capital LLC raised its position in Joint by 20.3% in the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock valued at $5,801,000 after purchasing an additional 101,850 shares during the last quarter. Boston Partners acquired a new stake in shares of Joint during the fourth quarter valued at about $279,000. Trexquant Investment LP grew its holdings in shares of Joint by 8.0% during the fourth quarter. Trexquant Investment LP now owns 82,686 shares of the company’s stock worth $795,000 after purchasing an additional 6,097 shares during the last quarter. Finally, Bard Associates Inc. increased its stake in shares of Joint by 4.3% in the fourth quarter. Bard Associates Inc. now owns 79,549 shares of the company’s stock valued at $764,000 after buying an additional 3,250 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

Analyst Upgrades and Downgrades

JYNT has been the topic of a number of recent research reports. Roth Mkm reiterated a “buy” rating and set a $16.00 target price (up previously from $13.00) on shares of Joint in a research note on Friday, May 3rd. B. Riley increased their price objective on Joint from $12.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, May 6th. Finally, StockNews.com raised shares of Joint from a “hold” rating to a “buy” rating in a research report on Monday, May 6th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.00.

Check Out Our Latest Stock Analysis on Joint

Joint Trading Down 0.3 %

JYNT stock traded down $0.05 during mid-day trading on Monday, hitting $14.25. The stock had a trading volume of 19,631 shares, compared to its average volume of 78,411. The firm has a fifty day simple moving average of $14.40 and a 200 day simple moving average of $12.73. Joint has a 52 week low of $7.31 and a 52 week high of $17.82. The firm has a market capitalization of $213.32 million, a P/E ratio of -19.00 and a beta of 1.60.

Joint (NASDAQ:JYNTGet Free Report) last released its earnings results on Thursday, May 2nd. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.09. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The firm had revenue of $29.72 million during the quarter, compared to analysts’ expectations of $29.17 million. As a group, equities analysts expect that Joint will post 0.2 earnings per share for the current fiscal year.

About Joint

(Get Free Report)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

See Also

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.